Providing COVID-19 support

Providing COVID-19 support

Thank you to the numerous Milner affiliated companies who have been in contact to offer support  to the University and NHS at this time. Help tackle COVID-19 through research collaborations, by donating equipment or funding research The University of Cambridge is...
Providing COVID-19 support

Milner Institute closure for COVID-19

As part of the response to COVID-19 at the University of Cambridge, the Milner Therapeutics Institute will be closed for non-essential business from Friday March 20th until further notice. Events planned for March and April, including the Milner seminar series, have...
Welcome to the Tzelepis Group

Welcome to the Tzelepis Group

We are delighted that Dr Konstantinos Tzelepis has moved into the Milner Centre for Pathway Analysis as a new Academic in Residence. He brings significant expertise in the identification and characterisation of novel therapeutic targets using a wide range of applied...
A look inside the institute

A look inside the institute

For the past four years, the Milner Therapeutics Institute has been incubating in the Gurdon Institute – home to the research lab of our Director Tony Kouzarides. This provided essential support as the Milner team was growing and developing key strategic partnerships,...
Launch of the Milner Therapeutics Institute

Launch of the Milner Therapeutics Institute

This month, we celebrated the launch of the Milner Therapeutics Institute in the Jeffrey Cheah Biomedical Centre. Key academics and consortium members gathered in our brand new auditorium. Our Director, Tony Kouzarides, gave the vision of the Milner Therapeutics...

Pin It on Pinterest